1. Margoni M, Preziosa P, Filippi M, et al. Anti-CD20 therapies for multiple sclerosis: current status and future perspectives. J Neurol. 2022;269(3):1316–34.
2. Peterson S, Jalil A, Beard K, et al. Updates on efficacy and safety outcomes of new and emerging disease modifying therapies and stem cell therapy for multiple sclerosis: a review. Mult Scler Relat Disord. 2022;68(104125):1–12.
3. Chmielewska N, Szyndler J. Targeting CD20 in multiple sclerosis: review of current treatment strategies. Neurol Neurochir Pol. 2023;57(3):235–42.
4. de Sèze J, Maillart E, Gueguen A, et al. Anti-CD20 therapies in multiple sclerosis: from pathology to the clinic. Front Immunol. 2023;14(1004795):1–23.
5. Kanatas P, Stouras I, Stefanis L, et al. B-cell-directed therapies: a new era in multiple sclerosis treatment. Can J Neurol Sci. 2023;50(3):355–64.